Integrated network pharmacology–transcriptomics revealed that suppressing inflammatory signals (IL-1β, IL-6, TNF, IκB–NF-κB, TLR, and MAPK) and apoptosis contributed to the anti-COPD property of QJHTD. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.